In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dow Corning Corp.

Latest From Dow Corning Corp.

Medtech Value Brands: Stepping Down May Boost The Top Line

The medtech industry has traditionally grown through innovation – new products with improved features and benefits have fueled revenue growth. However, innovation alone does not garner the price premium it once did, and manufacturers must decide whether to pursue a value brand strategy alongside their traditional premium brand, says global management consulting firm Simon-Kucher & Partners.

Pricing Strategies Business Strategies

Medherant Ltd.

Medherant Ltd. 's drug delivery patch technology can accommodate medium or low potency drugs at a suitable saturation level to permeate the skin but without compromising adhesion, which existing patch technology has failed to achieve. This means that low potency drugs such as ibuprofen – the company's first product – can now be formulated into a patch rather than only being available in topical gel or cream.

BioPharmaceutical

Medherant: Adhesive Patch For Transdermal Drug Delivery

Medherant Ltd.'s drug delivery patch technology can accommodate medium or low potency drugs at a suitable saturation level to permeate the skin but without compromising adhesion, which existing patch technology has failed to achieve. This means that low potency drugs such as ibuprofen – the company's first product – can now be formulated into a patch rather than only being available in topical gel or cream.

Medical Device BioPharmaceutical

People In Brief: Pfizer, Valeant, Vitalah, Aker, Mulberry Love

Schulman out, Bourla in at Pfizer; Valeant appoints Kellen chairman; Vitalah VP leads Oxylent sales; Aker names Australia head; CRN builds regulatory team; more People In Brief.

Consumer BioPharmaceutical
See All

Company Information

  • Industry
  • Diversified
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dow Corning Corp.
  • Senior Management
  • R. A Hazleton, Chmn. & CEO
    J. W Churchfield, VP & CFO
    Robert Rylee, II, VP & General Mgr., Health Care
  • Contact Info
  • Dow Corning Corp.
    Phone: (517) 496-4000
    2200 W. Salzburg Road
    Midland, MI 48686-0994
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register